Around one in 20 people in the UK have the skin condition rosacea, which causes a hot and red face as well as spots.
A drug used for migraines was found to help symptoms of rosaceaA migraine drug could be offered to sufferers of facial flushing after a study found it significantly reduced symptoms.
The jab blocks the effect of a protein which is linked to the debilitating headaches and nausea of migraine.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Positive response to Botox injection predicts better results of migraine surgeryPreoperative Botox injections are a useful test for predicting how well patients with chronic migraine will respond to nerve decompression surgery, reports a study in the May issue of Plastic and Reconstructive Surgery.
Weiterlesen »
Study links acid-reducing drugs to increased risk of migrainePeople who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology Clinical Practice, an official journal of the American Academy of Neurology.
Weiterlesen »
Use of acid reflux drugs linked to higher risk of migrainePeople who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology Clinical Practice.
Weiterlesen »
Migraine sufferers in England may soon be able to access a preventative drug: AtogepantA drug that can help prevent migraines could soon be available on the NHS. Atogepant (brand name: Aquipta) was recently recommended by the National Institute for Health and Care Excellence (NICE) to prevent episodic and chronic migraine attacks.
Weiterlesen »
A New Migraine Drug Is Coming To England, Here’s How To Get ItAtogepant wil be the first oral treatment for chronic and episodic migraines.
Weiterlesen »
Migraine breakthrough as new pill offered on NHS for the first timeAtogepant – sold under the brand name Aquipta and made by AbbVie – has been given the green light for NHS
Weiterlesen »